Evidence map›Paper›PMID 37367766›Full record

ArticleMembranes2023

Valorization of Seawater Reverse Osmosis Brine by Monovalent Ion-Selective Membranes through Electrodialysis.

Prem P Sharma, Shabin Mohammed, Jamaliah Aburabie, Raed Hashaikeh

Open access · goldAbstract read
In one paragraph

Article in Membranes, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 20 citations in OpenAlex.

  1. Advanced Bio-Membrane Technologies for Water Treatment: Mechanisms, Challenges, and Future Prospects-A Comprehensive Critical Review.Water environment research : a research publication of the Water Environment Federation · 2026
    Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Prem P SharmaNYUAD Water Research Center, Engineering Division, New York University Abu Dhabi, Abu Dhabi P.O. Box 129188, United Arab Emirates.
Shabin MohammedNYUAD Water Research Center, Engineering Division, New York University Abu Dhabi, Abu Dhabi P.O. Box 129188, United Arab Emirates.ORCID 0000-0002-1605-8253
Jamaliah AburabieNYUAD Water Research Center, Engineering Division, New York University Abu Dhabi, Abu Dhabi P.O. Box 129188, United Arab Emirates.
Raed HashaikehNYUAD Water Research Center, Engineering Division, New York University Abu Dhabi, Abu Dhabi P.O. Box 129188, United Arab Emirates.ORCID 0000-0002-0248-7495
New York University Abu Dhabi · AE

Funding

Tamkeen CG007
6 · The paper itself

Abstract

This paper proposes the use of monovalent selective electrodialysis technology to concentrate the valuable sodium chloride (NaCl) component present in seawater reverse osmosis (SWRO) brine for direct utilization in the chlor-alkali industry. To enhance monovalent selectivity, a polyamide selective layer was fabricated on commercial ion exchange membranes (IEMs) through interfacial polymerization (IP) of piperazine (PIP) and 1,3,5-Benzenetricarbonyl chloride (TMC). The IP-modified IEMs were characterized using various techniques to investigate changes in chemical structure, morphology, and surface charge. Ion chromatography (IC) analysis showed that the divalent rejection rate was more than 90% for IP-modified IEMs, compared to less than 65% for commercial IEMs. Electrodialysis results demonstrated that the SWRO brine was successfully concentrated to 14.9 g/L NaCl at a power consumption rate of 3.041 kWh/kg, indicating the advantageous performance of the IP-modified IEMs. Overall, the proposed monovalent selective electrodialysis technology using IP-modified IEMs has the potential to provide a sustainable solution for the direct utilization of NaCl in the chlor-alkali industry.

Indexed as

anion exchange membranebrine managementcation exchange membraneinterfacial polymerizationion exchange membranerejection

Identifiers

PMID37367766
PMCPMC10302217
OpenAlexW4378906396

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.